Lupus Research Alliance News
Lupus Therapeutics Collaborating with PPD to Accelerate Lupus Clinical Research

September 3, 2020 PPD, Inc. issued a press release  today announcing its collaboration with the Lupus Research Alliance affiliate Lupus Therapeutics to optimize lupus clinical research among its pharmaceutical and biotech clients. As a contract research organization, PPD helps its clients design and implement clinical trials. PPD expects to gain from Lupus Therapeutics’ deep clinical […] READ MORE

23andMe Study Confirms Lupus Can Run in Families and Other New Insights

August 25, 2020 A study started four years ago and conducted by 23andMe provided many insights about lupus as a complex disease that is extremely difficult to diagnose and treat. While the survey of nearly 6,000 participants did not find new genetic factors causing lupus as hoped, the study confirmed that lupus can run in […] READ MORE

Family Night with GoGo squeeZ

Go Go with Us for Family Fun Night August 26!  Enjoy a light-hearted demonstration of a nutritious kid-friendly recipe, celebrate fundraising successes with outstanding Walk Team Captains and hear an insider preview of the first and largest virtual lupus Walk Event September 12. EVENT DATE | TIME  August 26, 7:00 PM Eastern Time  PROGRAM Welcome […] READ MORE

Watch Webcast Video: Redefining Lupus Trials Amid COVID-19 and Beyond

Videotape of 8.24.20 Learn from Lupus Zoom Webcast Ensuring the clinical trial process is accommodating for participants has always been the goal. However, COVID-19 has forced industry, research organizations, doctors, and patients to think twice about the process and its impact on high-risk populations including people with lupus who are immunocompromised. In light of COVID-19, […] READ MORE

LRA-Supported Study Discovers How Harmful Immune Cells Develop

August 17, 2020 In a new study published in the journal Immunity, Lupus Research Alliance-funded researcher Dr. Boris Reizis and his colleagues identified conditions under which immune cells called B cells begin to attack healthy genetic material (DNA). Dr. Reizis’ findings highlight the potential of drugs such as anifrolumab and BIIB-059 as potential treatments for […] READ MORE

LRA Proudly Congratulates Dr. Lindsey Criswell on NIAMS Appointment

August 13, 2020 The Lupus Research Alliance is proud to congratulate one of our funded researchers, Lindsey A. Criswell, MD, MPH, DSc, on her new appointment as Director of the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). Currently Vice Chancellor of Research at the University of California, San Francisco, Dr. Criswell has […] READ MORE

NIH Leader and LRA Board Member Key Author on Promising COVID-19 Vaccine

August 13, 2020 The Lupus Research Alliance (LRA) is encouraged by a promising animal study in the New England Journal of Medicine co-authored by Robert Seder, MD, Chief of the Cellular Immunology Section in the Vaccine Research Center at the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health (NIH) […] READ MORE

Lupus Research Alliance Sets Bold New Strategic Plan for Research to Accelerate Innovative Research and Treatment Breakthroughs

August 12, 2020 The Lupus Research Alliance (LRA) today announced a bold new Strategic Plan for Research (Strategic Plan) that identifies core issues and sets new priorities to transform lupus research, accelerate breakthrough treatments and ultimately, find a cure through the power of precision medicine. The new Strategic Plan is informed by years of funded […] READ MORE

New LRA-Funded Study: Lupus Flares are Linked to E-Coli Bacteria Levels

August, 2020 A new study led by Dr. Roberto Caricchio, Dr. Stefania Gallucci and Dr. Cagla Tukel, funded by the Lupus Research Alliance, has shown that lupus flares are associated with high levels of antibodies against a specific bacterial protein, called curli. Published in Arthritis and Rheumatology, the study also showed that high levels of […] READ MORE

A Potential Test to Monitor Lupus Disease Severity Supported by LRA Grant

August 6, 2020 Christian Lood, PhD, at the University of Washington, has developed a new method to assess lupus disease severity. It relies on measuring immune complexes, which are the substances that form when antibodies recognize and attach to a particular target in the body. In systemic lupus erythematosus (SLE) and other autoimmune diseases, these […] READ MORE

House Approves $10 Million for Lupus Research Funding!

July 31, 2020 In early July we alerted you that the Fiscal Year (FY) 2021 Defense Appropriations Bill was publicly announced with $10 million appropriated for the Lupus Research Program at the Department of Defense. We are thrilled to announce that the House of Representatives today passed this Bill! The many, many phone calls and […] READ MORE

Learn and connect with our community!